AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 MAR 3 - (NewsRx.com & NewsRx.net) -- NanoPass Technologies, Ltd., has signed an agreement with GlaxoSmithKline's Biopharmaceutical Centre of Excellence for Drug Discovery (GSK) to develop NanoPass' MicroPyramid technology for the delivery of vaccines.
The aim of the collaboration is to optimize the MicroPyramid platform for vaccine delivery. The MicroPyramid technology offers the possibility to effectively and painlessly administer vaccines intra-epidermally. Conventional needles are too large to do this, and transdermal patch or chemical technologies are incapable of ...